These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11897420)

  • 1. rhEGF/HP-beta-CD complex in poloxamer gel for ophthalmic delivery.
    Kim EY; Gao ZG; Park JS; Li H; Han K
    Int J Pharm; 2002 Feb; 233(1-2):159-67. PubMed ID: 11897420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hydroxypropyl beta-cyclodextrin on the self-assembling and thermogelation properties of Poloxamer 407.
    Bonacucina G; Spina M; Misici-Falzi M; Cespi M; Pucciarelli S; Angeletti M; Palmieri GF
    Eur J Pharm Sci; 2007 Oct; 32(2):115-22. PubMed ID: 17656076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization and physicochemical characterization of thermosensitive poloxamer gel containing puerarin for ophthalmic use.
    Qi H; Li L; Huang C; Li W; Wu C
    Chem Pharm Bull (Tokyo); 2006 Nov; 54(11):1500-7. PubMed ID: 17077546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbopol-incorporated thermoreversible gel for intranasal drug delivery.
    Balakrishnan P; Park EK; Song CK; Ko HJ; Hahn TW; Song KW; Cho HJ
    Molecules; 2015 Mar; 20(3):4124-35. PubMed ID: 25749681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
    Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalein and hydroxypropyl-γ-cyclodextrin complex in poloxamer thermal sensitive hydrogel for vaginal administration.
    Zhou Q; Zhong L; Wei X; Dou W; Chou G; Wang Z
    Int J Pharm; 2013 Sep; 454(1):125-34. PubMed ID: 23850236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.
    Cho HJ; Balakrishnan P; Park EK; Song KW; Hong SS; Jang TY; Kim KS; Chung SJ; Shim CK; Kim DD
    J Pharm Sci; 2011 Feb; 100(2):681-91. PubMed ID: 20803575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations in the use of hydroxypropyl-beta-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone.
    Bary AR; Tucker IG; Davies NM
    Eur J Pharm Biopharm; 2000 Sep; 50(2):237-44. PubMed ID: 10962233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin.
    Evrard B; Chiap P; DeTullio P; Ghalmi F; Piel G; Van Hees T; Crommen J; Losson B; Delattre L
    J Control Release; 2002 Dec; 85(1-3):45-50. PubMed ID: 12480310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budesonide-hydroxypropyl-β-cyclodextrin inclusion complex in binary poloxamer 407/403 system for ulcerative colitis treatment: A physico-chemical study from micelles to hydrogels.
    Santos Akkari AC; Ramos Campos EV; Keppler AF; Fraceto LF; de Paula E; Tófoli GR; de Araujo DR
    Colloids Surf B Biointerfaces; 2016 Feb; 138():138-47. PubMed ID: 26674842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery.
    McCormack B; Gregoriadis G
    Biochim Biophys Acta; 1996 Dec; 1291(3):237-44. PubMed ID: 8980638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of hydroxypropyl beta-cyclodextrin on the corneal permeation of pilocarpine.
    Aktaş Y; Unlü N; Orhan M; Irkeç M; Hincal AA
    Drug Dev Ind Pharm; 2003 Feb; 29(2):223-30. PubMed ID: 12648019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat.
    Tricarico D; Maqoud F; Curci A; Camerino G; Zizzo N; Denora N; Cutrignelli A; Laquintana V; Lopalco A; la Forgia F; Fontana S; Franco M; Lopedota A
    Eur J Pharm Biopharm; 2018 Jan; 122():146-157. PubMed ID: 29079420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Use of Cyclodextrin Complexes for Enhanced Stability, Anti-inflammatory Efficacy, and Ocular Bioavailability of Loteprednol Etabonate.
    Soliman OAE; Mohamed EAM; El-Dahan MS; Khatera NAA
    AAPS PharmSciTech; 2017 May; 18(4):1228-1241. PubMed ID: 27469220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hydroxypropyl-β-cyclodextrin on the ocular bioavailability of dexamethasone from a pH-induced mucoadhesive hydrogel.
    Kesavan K; Kant S; Singh PN; Pandit JK
    Curr Eye Res; 2011 Oct; 36(10):918-29. PubMed ID: 21950697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal lontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-beta-cyclodextrin complexes.
    Doliwa A; Santoyo S; Ygartua P
    Drug Dev Ind Pharm; 2001 Sep; 27(8):751-8. PubMed ID: 11699826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery.
    Nogueiras-Nieto L; Sobarzo-Sánchez E; Gómez-Amoza JL; Otero-Espinar FJ
    Eur J Pharm Biopharm; 2012 Apr; 80(3):585-95. PubMed ID: 22182528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: In vitro drug release and in vivo tissue distribution.
    Wei Y; Li C; Zhu Q; Zhang X; Guan J; Mao S
    Int J Pharm; 2020 Mar; 578():119184. PubMed ID: 32112932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.
    Jansook P; Pichayakorn W; Muankaew C; Loftsson T
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.